BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 11759056)

  • 1. Expression of CD44S and CD44v5 is more common in stage III than in stage I serous ovarian carcinomas.
    Afify AM; Ferguson AW; Davila RM; Werness BA
    Appl Immunohistochem Mol Morphol; 2001 Dec; 9(4):309-14. PubMed ID: 11759056
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of the hyaluronan receptor, CD44S, in epithelial ovarian cancer is an independent predictor of survival.
    Kayastha S; Freedman AN; Piver MS; Mukkamalla J; Romero-Guittierez M; Werness BA
    Clin Cancer Res; 1999 May; 5(5):1073-6. PubMed ID: 10353740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Value of mesothelial and epithelial antibodies in distinguishing diffuse peritoneal mesothelioma in females from serous papillary carcinoma of the ovary and peritoneum.
    Attanoos RL; Webb R; Dojcinov SD; Gibbs AR
    Histopathology; 2002 Mar; 40(3):237-44. PubMed ID: 11895489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of CD44s, CD44v6, and hyaluronan across the spectrum of normal-hyperplasia-carcinoma in breast.
    Afify A; McNiel MA; Braggin J; Bailey H; Paulino AF
    Appl Immunohistochem Mol Morphol; 2008 Mar; 16(2):121-7. PubMed ID: 18227732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD44 variant 6 is correlated with peritoneal dissemination and poor prognosis in patients with advanced epithelial ovarian cancer.
    Tjhay F; Motohara T; Tayama S; Narantuya D; Fujimoto K; Guo J; Sakaguchi I; Honda R; Tashiro H; Katabuchi H
    Cancer Sci; 2015 Oct; 106(10):1421-8. PubMed ID: 26250934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Temporal variation in the distribution of hyaluronic acid, CD44s, and CD44v6 in the human endometrium across the menstrual cycle.
    Afify AM; Craig S; Paulino AF
    Appl Immunohistochem Mol Morphol; 2006 Sep; 14(3):328-33. PubMed ID: 16932025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differentiation of mesothelioma from adenocarcinoma in serous effusions: the role of hyaluronic acid and CD44 localization.
    Afify AM; Stern R; Michael CW
    Diagn Cytopathol; 2005 Mar; 32(3):145-50. PubMed ID: 15690337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of CD44(v5-10) splicing variants in primary ovarian cancer and lymph node metastases.
    Schröder W; Rudlowski C; Biesterfeld S; Knobloch C; Hauptmann S; Rath W
    Anticancer Res; 1999; 19(5B):3901-6. PubMed ID: 10628329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD44 and hyaluronate in the differential diagnosis of dermatofibroma and dermatofibrosarcoma protuberans.
    Calikoglu E; Augsburger E; Chavaz P; Saurat JH; Kaya G
    J Cutan Pathol; 2003 Mar; 30(3):185-9. PubMed ID: 12641778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased CD44 standard form expression correlates with prognostic variables in ovarian carcinomas.
    Ross JS; Sheehan CE; Williams SS; Malfetano JH; Szyfelbein WM; Kallakury BV
    Am J Clin Pathol; 2001 Jul; 116(1):122-8. PubMed ID: 11447742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of CD44s, CD44v5, CD44v6 and CD44v7-8 in betel quid chewing-associated oral premalignant lesions and squamous cell carcinomas in Taiwan.
    Kuo MY; Cheng SJ; Chen HM; Kok SH; Hahn LJ; Chiang CP
    J Oral Pathol Med; 1998 Oct; 27(9):428-33. PubMed ID: 9790096
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation of CD44v6 expression with ovarian cancer progression and recurrence.
    Shi J; Zhou Z; Di W; Li N
    BMC Cancer; 2013 Apr; 13():182. PubMed ID: 23565736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Binding of ovarian cancer cells to immobilized hyaluronic acid.
    Catterall JB; Gardner MJ; Jones LM; Turner GA
    Glycoconj J; 1997 Nov; 14(7):867-9. PubMed ID: 9511993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased expression of CD44 splicing variants in advanced colorectal carcinomas.
    Weg-Remers S; Anders M; von Lampe B; Riecken EO; Schüder G; Feifel G; Zeitz M; Stallmach A
    Eur J Cancer; 1998 Sep; 34(10):1607-11. PubMed ID: 9893637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of CD44 in effusions of patients diagnosed with serous ovarian carcinoma--diagnostic and prognostic implications.
    Berner HS; Davidson B; Berner A; Risberg B; Kristensen GB; Trope CG; Van de Putte G; Nesland JM
    Clin Exp Metastasis; 2000; 18(2):197-202. PubMed ID: 11235996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of E-cadherin, alpha-catenin, beta-catenin, and CD44 (standard and variant isoforms) in human cholangiocarcinoma: an immunohistochemical study.
    Ashida K; Terada T; Kitamura Y; Kaibara N
    Hepatology; 1998 Apr; 27(4):974-82. PubMed ID: 9537436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD44 standard form expression is correlated with high-grade and advanced-stage ovarian carcinoma but not prognosis.
    Zhang J; Chang B; Liu J
    Hum Pathol; 2013 Sep; 44(9):1882-9. PubMed ID: 23664487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential expression of CD44v6 in metastases of intestinal and diffuse types of gastric carcinoma.
    Castellà EM; Ariza A; Pellicer I; Fernández-Vasalo A; Ojanguren I
    J Clin Pathol; 1998 Feb; 51(2):134-7. PubMed ID: 9602687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of hyaluronic acid and its receptors, CD44s and CD44v6, in normal, hyperplastic, and neoplastic endometrium.
    Afify AM; Craig S; Paulino AF; Stern R
    Ann Diagn Pathol; 2005 Dec; 9(6):312-8. PubMed ID: 16308159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of CD44 splice variants in squamous epithelia and squamous cell carcinomas of the head and neck.
    Herold-Mende C; Seiter S; Born AI; Patzelt E; Schupp M; Zöller J; Bosch FX; Zöller M
    J Pathol; 1996 May; 179(1):66-73. PubMed ID: 8691348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.